RTTR - Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals, Inc.

1880 Century Park East
Suite 1000
Los Angeles, CA 90067
United States
310-203-1000
http://www.ritterpharmaceuticals.com

Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 7

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Ira Eliot Ritter	Co-Founder, Exec. Chairman & Chief Strategic Officer	446.06k	N/A	1949
Mr. Andrew J. Ritter	Co-Founder, CEO, Pres, Corp. Sec. & Director	579.69k	N/A	1983
Mr. John W. Beck CPA, CPA	Chief Financial Officer	355.07k	N/A	1960
Ms. Ellen F. Mochizuki	Consultant	N/A	N/A	1967

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Ritter Pharmaceuticals, Inc. develops and sells therapeutic products that modulate the gut microbiome to treat digestive disorders and gastrointestinal diseases. Its lead product candidate is RP-G28, an orally administered galacto-oligosaccharide that is in Phase III clinical trials for the treatment of lactose intolerance. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.

Corporate Governance

Ritter Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.